Fcpm Iii Services B.V. Bicycle Therapeutics PLC Transaction History
Fcpm Iii Services B.V.
- $592 Billion
- Q4 2024
A detailed history of Fcpm Iii Services B.V. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 3,452,330 shares of BCYC stock, worth $41.4 Million. This represents 8.16% of its overall portfolio holdings.
Number of Shares
3,452,330
Previous 2,339,961
47.54%
Holding current value
$41.4 Million
Previous $53 Billion
8.73%
% of portfolio
8.16%
Previous 9.09%
Shares
3 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$131 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$54.7 Million0.15% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$31.3 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$26.4 Million0.43% of portfolio
-
Siren, L.L.C. New York, NY1.84MShares$22.1 Million1.14% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $356M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...